Expertise in
2
conditions

Wei-li Ma

TPQ, TW 
Expertise in
2
conditions
TPQ, TW 

Overview

Wei-li Ma practices practicing medicine in Taiwan.

Ma is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Thymic Epithelial Tumor, Peripheral T-Cell Lymphoma, and Thymectomy.

They are actively involved in clinical research, co-authoring 21 peer reviewed articles and participating in 2 clinical trials.

Locations

TPQ, Taiwan
Other Locations
Yun Lin Branch, Yun Lin, Dawan, TNQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Named Patient Use Program to Provide Abemaciclib for the Treatment of Metastatic Breast Cancer
Named Patient Use Program to Provide Abemaciclib for the Treatment of Metastatic Breast Cancer
Enrollment Status: Approved_for_marketing
Publish Date: December 16, 2024
Intervention Type: Drug
A Single Arm，Phase Ib/II Study of the Combination of Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas (PTCL)
A Single Arm，Phase Ib/II Study of the Combination of Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas (PTCL)
Enrollment Status: Terminated
Publish Date: July 08, 2024
Intervention Type: Drug
Study Drug: Lenalidomide+Gemcitabine
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

21 Total Publications

Increased CCR5 expression in lymphoma cells and M2 macrophages is associated with poor prognosis in primary intestinal diffuse large B-cell lymphoma.
Increased CCR5 expression in lymphoma cells and M2 macrophages is associated with poor prognosis in primary intestinal diffuse large B-cell lymphoma.
Journal: The journal of pathology. Clinical research
Published: April 11, 2026

Frequently Asked Questions about Wei-li Ma

Is Wei-li Ma a top-rated expert for B-Cell Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Wei-li Ma is classified as an Advanced expert for B-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Wei-li Ma participate in research or clinical trials?

Yes. Wei-li Ma has published 21 articles and abstracts on conditions like B-Cell Lymphoma. You can view a list of Wei-li Ma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ma's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile